Never‐smoking nonsmall cell lung cancer as a separate entity

To propose ‘never‐smoking nonsmall cell lung cancer (NSCLC)’ as a separate entity, the clinicopathologic differences of operable NSCLC between never‐smoking patients and patients with a history of smoking were investigated.

[1]  E. Tan,et al.  The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis. , 2004, Chest.

[2]  R. Wilson,et al.  Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Koong,et al.  Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Wilson,et al.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[6]  P. Brennan,et al.  Incidence of lung cancer in a large cohort of non‐smoking men from Sweden , 2001, International journal of cancer.

[7]  J. Minna,et al.  Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features , 2006, Clinical Cancer Research.

[8]  Takayuki Kosaka,et al.  Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer , 2004, Cancer Research.

[9]  L. Tanoue.  The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer: A Retrospective AnalysisToh C-K, Wong E-H, Lim W-T, et al (Natl Cancer Ctr, Singapore) Chest 126:1750-1756, 2004§ , 2006 .

[10]  S. Anttila,et al.  Survival in operable non‐small‐cell lung cancer: Role of p53 mutations, tobacco smoking and asbestos exposure , 2000, International journal of cancer.

[11]  Karl-Heinz Jöckel,et al.  Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: A pooled analysis of two large studies , 2004, International journal of cancer.

[12]  F. Gao,et al.  Presentation and Stage-Specific Outcomes of Lifelong Never-smokers with Non-small Cell Lung Cancer (NSCLC) , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[14]  L. Holmberg,et al.  Lung cancer incidence in never smokers. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  K. Hiroshima,et al.  Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[17]  E. van Marck,et al.  Prognostic value of smoking status in operated non-small cell lung cancer. , 2005, Lung cancer.

[18]  S. Ou,et al.  bronchioloalveolar carcinoma : Improvement in survival after release of the 1999 WHO classification of lung tumors , 2006 .

[19]  P. Kvale,et al.  Smoking and lung cancer survival: the role of comorbidity and treatment. , 2004, Chest.

[20]  Y. Maehara,et al.  Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. , 2006, The Annals of thoracic surgery.

[21]  M. Usel,et al.  Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. , 2000, The Journal of thoracic and cardiovascular surgery.

[22]  E. Vokes,et al.  Sex-associated differences in survival of patients undergoing resection for lung cancer. , 2000, The Annals of thoracic surgery.

[23]  R. Severson,et al.  Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. , 2005, Chest.

[24]  J H Ho,et al.  Worldwide epidemiological patterns of lung cancer in nonsmokers. , 1990, International journal of epidemiology.

[25]  G. Bepler,et al.  Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. , 2004, Chest.

[26]  J. Hanley,et al.  Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. , 2000, Lung cancer.

[27]  K. Sugimachi,et al.  Longer survival after resection of non-small cell lung cancer in Japanese women. , 1989, The Annals of thoracic surgery.